Stockreport

Aviragen Comments on ISS Report

Atea Pharmaceuticals, Inc. - common stock  (AVIR) 
PDF Vaxart Merger is the Result of an Extensive Review of Strategic Alternatives and is in the Best Interest of ALL Stockholders Aviragen Board of Directors Unanimously Rec [Read more]